Sheng‐Nan Lu

17.5k total citations · 2 hit papers
379 papers, 12.3k citations indexed

About

Sheng‐Nan Lu is a scholar working on Hepatology, Epidemiology and Surgery. According to data from OpenAlex, Sheng‐Nan Lu has authored 379 papers receiving a total of 12.3k indexed citations (citations by other indexed papers that have themselves been cited), including 307 papers in Hepatology, 300 papers in Epidemiology and 37 papers in Surgery. Recurrent topics in Sheng‐Nan Lu's work include Liver Disease Diagnosis and Treatment (261 papers), Hepatitis C virus research (226 papers) and Hepatitis B Virus Studies (216 papers). Sheng‐Nan Lu is often cited by papers focused on Liver Disease Diagnosis and Treatment (261 papers), Hepatitis C virus research (226 papers) and Hepatitis B Virus Studies (216 papers). Sheng‐Nan Lu collaborates with scholars based in Taiwan, United States and China. Sheng‐Nan Lu's co-authors include Jing‐Houng Wang, San‐Lin You, Hwai‐I Yang, Tsung‐Hui Hu, Chien‐Hung Chen, Chuan–Mo Lee, Chi‐Sin Changchien, Chao‐Hung Hung, Pei‐Jer Chen and Chao‐Hung Hung and has published in prestigious journals such as New England Journal of Medicine, Journal of Clinical Oncology and SHILAP Revista de lepidopterología.

In The Last Decade

Sheng‐Nan Lu

365 papers receiving 12.0k citations

Hit Papers

align trajectories

What are hit papers?

Hit papers significantly outperform the citation benchmark for their cohort. A paper qualifies if it has ≥500 total citations, achieves ≥1.5× the top-1% citation threshold for papers in the same subfield and year (this is the minimum needed to enter the top 1%, not the average within it), or reaches the top citation threshold in at least one of its specific research topics.

Hepatitis B e Antigen and the Risk of Hepatocellular Carcinoma

2002 926 citations Hwai‐I Yang, Sheng‐Nan Lu et al. profile →
Chronic Hepatitis C Virus Infection Increases Mortality From Hepatic and Extrahepatic Diseases: A Community-Based Long-Term Prospective Study

2012 398 citations Mei–Hsuan Lee, Hwai‐I Yang et al. profile →

Peers

Countries citing papers authored by Sheng‐Nan Lu

Since Specialization

Citations

This map shows the geographic impact of Sheng‐Nan Lu's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Sheng‐Nan Lu with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Sheng‐Nan Lu more than expected).

Fields of papers citing papers by Sheng‐Nan Lu

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Sheng‐Nan Lu. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Sheng‐Nan Lu. The network helps show where Sheng‐Nan Lu may publish in the future.

Co-authorship network of co-authors of Sheng‐Nan Lu

This figure shows the co-authorship network connecting the top 25 collaborators of Sheng‐Nan Lu. A scholar is included among the top collaborators of Sheng‐Nan Lu based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Sheng‐Nan Lu. Sheng‐Nan Lu is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

#	Work	Indexed citations
1	Survival outcome with liver resection versus percutaneous radiofrequency ablation in patients with 2–3 cm single hepatocellular carcinoma 2025 ·Asian Journal of Surgery ·Yi‐Hao Yen, (unknown), Sheng‐Nan Lu, Tsung‐Hui Hu, Jing‐Houng Wang, Chao‐Hung Hung, Chien‐Hung Chen, Kwong‐Ming Kee, Chee‐Chien Yong, Weifeng Li, Chih‐Chi Wang, (unknown)	0
2	Significant Decline in HCV ‐Related Mortality From Liver Cirrhosis and Chronic Liver Disease (2015–2022): A Sentinel Center Study 2025 ·Liver International ·(unknown), Chih‐Yun Lin, Jing‐Houng Wang, Chun‐Yen Lin, Rong‐Nan Chien, Sheng‐Nan Lu	0
3	Overall survival is comparable between percutaneous radiofrequency ablation and liver resection as first-line therapies for solitary 3–5 cm hepatocellular carcinoma 2025 ·Langenbeck s Archives of Surgery ·(unknown), Chee‐Chien Yong, Kwong‐Ming Kee, Sheng‐Nan Lu, Tsung‐Hui Hu, Jing‐Houng Wang, Chao‐Hung Hung, Chien‐Hung Chen, (unknown), Weifeng Li, Chih‐Chi Wang, (unknown), (unknown)	1
4	Survival benefit of sequential curative treatment for TACE suitable BCLC stage B HCC patients 2024 ·Scientific Reports ·(unknown), Te‐Sheng Chang, Chien‐Heng Shen, Liang-Mou Kuo, (unknown), Yi‐Hsing Chen, Yung‐Yu Hsieh, Hui‐Ling Huang, Sheng‐Nan Lu	2
5	Weight Gain and Increased Body Mass Index in Patients with Hepatitis C after Eradication Using Direct-Acting Antiviral Therapy in Taiwan 2024 ·Diagnostics ·(unknown), Yung‐Yu Hsieh, Wei‐Ming Chen, Chien‐Heng Shen, Kuo‐Liang Wei, (unknown), (unknown), Sheng‐Nan Lu, Chao‐Hung Hung, Te‐Sheng Chang	1
6	Comparing Carotid Artery Velocities with Current ASCVD Risk Stratification: A Novel Approach to Simpler Risk Assessment 2024 ·Journal of Epidemiology and Global Health ·(unknown), (unknown), Sheng‐Nan Lu, Fu‐Wen Liang, Hung‐Yi Chuang	0
7	Persistently high HBsAg levels during HBeAg‐seropositive stage predict lower risk of hepatocellular carcinoma in chronic hepatitis B patients 2024 ·Alimentary Pharmacology & Therapeutics ·(unknown), Wen‐Juei Jeng, Jessica Liu, (unknown), Mei‐Hsuan Lee, Richard Batrla‐Utermann, Sheng‐Nan Lu, (unknown), Hwai‐I Yang, Chien‐Jen Chen	1
8	Factors Associated with Large Renal Function Decline in Patients with Chronic Hepatitis C Successfully Treated with Direct-Acting Antiviral Therapy 2023 ·Diagnostics ·Chun‐Hsien Chen, Chien‐Heng Shen, Kuo‐Liang Wei, Huang‐Wei Xu, Wei‐Ming Chen, (unknown), Yu‐Ting Huang, Yung‐Yu Hsieh, Sheng‐Nan Lu, Chao‐Hung Hung, Te‐Sheng Chang	1
9	Short Half-Life of Des-γ-Carboxy Prothrombin Is a Superior Factor for Early Prediction of Outcomes of Hepatocellular Carcinoma Treated with Radiofrequency Ablation 2023 ·Diagnostics ·Chih‐Chien Yao, Jing‐Houng Wang, Chien‐Hung Chen, Chao‐Hung Hung, Yi‐Hao Yen, Kwong‐Ming Kee, Tsung‐Hui Hu, Ming‐Chao Tsai, Yuan‐Hung Kuo, Sheng‐Nan Lu	2
10	Community-based screening by Anti-HCV reflex HCV Ag test and accessible post-screening care toward elimination of hepatitis C in two hyperendemic townships 2022 ·Journal of the Formosan Medical Association ·Kwong‐Ming Kee, Wei‐Ming Chen, (unknown), Jing‐Houng Wang, (unknown), Yu–Chen Lin, Sheng‐Nan Lu	4
11	High viral load predicts virologic failure in chronic genotype 2 hepatitis C virus-infected patients receiving glecaprevir/pibrentasvir therapy 2020 ·Journal of the Formosan Medical Association ·Wei‐Ming Chen, Kuo‐Liang Wei, Shui‐Yi Tung, Chien‐Heng Shen, Te‐Sheng Chang, Chih‐Wei Yen, Yung‐Yu Hsieh, (unknown), (unknown), Sheng‐Nan Lu, Chao‐Hung Hung	4
12	Usefulness of quantitative hepatitis B surface antigen testing in hepatitis B community-based screening 2020 ·Journal of the Formosan Medical Association ·(unknown), (unknown), Te‐Sheng Chang, Chao‐Hung Hung, Wei‐Ming Chen, Mei‐Yen Chen, Tung‐Jung Huang, (unknown), Jinghong Hu, Yu‐Chih Lin, Weicheng Huang, (unknown), Sheng‐Nan Lu	3
13	Level of Hepatitis B (HB) Core Antibody Associates With Seroclearance of HBV DNA and HB Surface Antigen in HB e Antigen-Seronegative Patients 2018 ·Clinical Gastroenterology and Hepatology ·Hui-Han Hu, Jessica Liu, (unknown), Chin–Lan Jen, Mei‐Hsuan Lee, Sheng‐Nan Lu, Li‐Yu Wang, Quan Yuan, Ningshao Xia, Chien‐Jen Chen, Pei‐Jer Chen, Hwai‐I Yang	25
14	Hepatitis C viral load, genotype, and increased risk of developing end‐stage renal disease: REVEAL‐HCV study 2017 ·Hepatology ·Tai‐Shuan Lai, Mei‐Hsuan Lee, Hwai‐I Yang, San‐Lin You, Sheng‐Nan Lu, Li‐Yu Wang, Yong Yuan, Gilbert L’Italien, Kuo‐Liong Chien, Chien‐Jen Chen, (unknown)	53
15	Alcohol Drinking Mediates the Association between Polymorphisms of ADH1B and ALDH2 and Hepatitis B–Related Hepatocellular Carcinoma 2016 ·Cancer Epidemiology Biomarkers & Prevention ·Jessica Liu, Hwai‐I Yang, Mei–Hsuan Lee, Chin–Lan Jen, Hui-Han Hu, Sheng‐Nan Lu, Li‐Yu Wang, San‐Lin You, Yen‐Tsung Huang, Chien‐Jen Chen	35
16	Baseline and serial liver stiffness measurement in prediction of portal hypertension progression for patients with compensated cirrhosis 2014 ·Liver International ·Jing‐Houng Wang, Seng‐Kee Chuah, Sheng‐Nan Lu, Chao‐Hung Hung, Chung‐Mou Kuo, Wei‐Chen Tai, Shue‐Shian Chiou	36
17	Intra-Arterial Chemotherapy with Doxorubicin and Cisplatin Is Effective for Advanced Hepatocellular Cell Carcinoma 2014 ·The Scientific World JOURNAL ·Ming‐Chun Ma, Yen‐Yang Chen, Shau-Hsuan Li, Yu‐Fan Cheng, Chih‐Chi Wang, Tai‐Jan Chiu, Sung‐Nan Pei, Chien-Ting Liu, Tai‐Lin Huang, (unknown), Yu‐Li Su, Yen‐Hao Chen, Sheng‐Nan Lu, Kun‐Ming Rau	14
18	Predictability of Liver-Related Seromarkers for the Risk of Hepatocellular Carcinoma in Chronic Hepatitis B Patients 2013 ·PLoS ONE ·(unknown), (unknown), Hwai‐I Yang, Chin–Lan Jen, San‐Lin You, Li‐Yu Wang, Sheng‐Nan Lu, Jessica Liu, Chien-Jen Chen	38
19	Association of amino acid variations in the NS5A and E2‐PePHD region of hepatitis C virus 1b with hepatocellular carcinoma 2007 ·Journal of Viral Hepatitis ·Chien‐Hui Hung, Chien‐Hung Chen, C.‐M. Lee, Cheng‐Kun Wu, Tsung‐Hui Hu, (unknown), Yi‐Hao Yen, Sheng‐Nan Lu	23
20	Abdominal sonographic screening in a single community. 1990 ·PubMed ·Sheng‐Nan Lu, Liang‐Yen Wang, Wen‐Yu Chang, Chien‐Jen Chen, (unknown), (unknown), Wan‐Long Chuang, Ming‐Yuh Hsieh	14

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact